Free shipping on all orders over $ 500

BETd-260

Cat. No. M10793

All AbMole products are for research use only, cannot be used for human consumption.

BETd-260 Structure
Synonym:

ZBC 260

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

BETd-260 (ZBC 260) is a PROTAC connected by the Cereblon ligand and bet ligands in leukemia cells RS4; 11 At low concentrations of 30 pM, BRD4 protein activity is reduced. BETd-260 significantly inhibits the activity of HCC cells in hepatocellular carcinoma and induces apoptosis.

Chemical Information
Molecular Weight 798.89
Formula C43H46N10O6
CAS Number 2093388-62-4
Solubility (25°C) DMSO ≥ 20 mg/mL
Storage -80°C, protect from light, dry, sealed
References

[1] Huapeng Zhang, et al. Front Oncol. Targeting BET Proteins With a PROTAC Molecule Elicits Potent Anticancer Activity in HCC Cells

[2] Chengcheng Shi, et al. Cell Death Dis. PROTAC induced-BET protein degradation exhibits potent anti-osteosarcoma activity by triggering apoptosis

[3] Bing Zhou, et al. J Med Chem. Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression

[4] Longchuan Bai, et al. Cancer Res. Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer

Related PROTAC Products
CR8

CR8 is a potent and selective inhibitor of cyclin dependent kinase (CDK1, 2, 5, 7, and 9).

ARV-393

ARV-393 is an orally active PROTAC degrader targeting BCL6 for studies related to diffuse large B-cell lymphoma. ARV-393 utilizes the ubiquitin-proteasome system to target the degradation of BCL6.

ARV-766

ARV-766 is an orally active and potent proteolysis targeting chimera (PROTAC) protein degrader. ARV-766 degrades wild-type androgen receptor (AR) but also relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations. ARV-766 has the potential to be first- and best-in class PROTAC AR degrader in mCRPC.

Indisulam

Indisulam is a carbonic anhydrase inibitor and antitumor CDK inhibitor. Indisulam targets the G1 phase of the cell cycle by depleting cyclin E. inducing p53 and p21, and inhibiting CDK2, causing a blockade in the G1/S transition.

dBET6

dBET6 is a highly potent, selective and cell-permeable PROTAC connected by ligands for Cereblon and BET, with an IC50 of 14 nM, and has antitumor activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: BETd-260, ZBC 260 supplier, PROTAC, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.